Applied DNA to Report First Quarter Fiscal 2024 Financial Results on Thursday, February 8, 2024
STONY BROOK, NY / ACCESSWIRE / February 5, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"),...
Year: 2024
Scryb Announces Late Filing
Toronto, Ontario--(Newsfile Corp. - February 5, 2024) - Scryb Inc. (CSE: SCYB) (OTCQB: SCYRF) (FSE: EIY) ("Scryb'' or the "Company") announces that...
Iodine Software Introduces AwareUM, a New Solution That Helps Hospitals Streamline Utilization Management and Strengthen Revenue Integrity
Built on Iodine's industry-leading CognitiveML engine, AwareUM emulates clinical thinking to improve productivity and meet medical necessity requirementsAUSTIN, TX /...
Bristol Myers Squibb Named One of America’s Most JUST Companies by JUST Capital and CNBC
Bristol Myers Squibb Company ranks in top 10 of Pharmaceutical and Biotech Sector on the issues Americans care about mostPRINCETON,...
Houston-Based resTOR Longevity Clinic to Offer Cardio Diagnostics’ AI-Driven Epigenetic-Genetic Heart Disease Tests
resTOR to be the first longevity clinic nationwide to offer the Company's blood-based epigenetic-genetic cardiovascular disease testsCHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings,...
Outset Medical to Report Fourth Quarter and Full-Year 2023 Financial Results on Wednesday, February 21, 2024
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the...
RingCentral Modernizes Patient Care Communications for Healthcare Organizations With New EHR Integrations and Generative AI
BELMONT, Calif.--(BUSINESS WIRE)--RingCentral, Inc. (NYSE: RNG), a leading provider of AI-first global enterprise cloud communications, video, webinars, hybrid events, and...
LivaNova Announces Vladimir A. Makatsaria as CEO and Board Director
William Kozy will remain Board ChairLONDON--(BUSINESS WIRE)--#cardiacsurgery--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced its Board of...
VitalHub Corp. Announces Acquisition of BookWise Solutions Limited
Toronto, Ontario--(Newsfile Corp. - February 5, 2024) - VITALHUB CORP. (TSX: VHI) (OTCQX: VHIBF) (the "Company" or "VitalHub") is pleased...
CLS Health Empowers Physicians with Operational Support
CLS Health, the largest physician-owned and physician-led organization in Houston with more than 33 locations, emphasizes the satisfaction and empowerment...
MentalHealth.com Appoints Co-Founder Jeff Smith to Venture Advisory Team and Digital Operations
SAN FRANCISCO, CA / ACCESSWIRE / February 5, 2024 / Leading health technology company MentalHealth.com is pleased to announce the...
Clarity Clinic Earns Prestigious Accreditation From the Joint Commission
Clarity Clinic receives the Gold Seal of Approval® in health care by demonstrating continuous compliance with its performance standards.CHICAGO, IL...
Ainos Submits Clinical Hold Complete Response to US FDA to Resolve the Deficiencies on Investigational New Drug Phase II Trial of its VELDONA Formulation Against Mild COVID-19 Symptoms
Updated Chemistry, Manufacturing, and Controls and Stability Test fulfill Ainos' development objectivesResolving the identified deficiencies will accelerate the timeline for...
OptiBrand Rx Announces Partnership With Miami Dolphins
MONTCLAIR, NJ / ACCESSWIRE / February 5, 2024 / OptiBrand Rx (OBRx), a globally renowned healthcare centric strategic brand positioning...
Researchers at KFSH&RC & KAUST Discover Gene Responsible for Reproduction of the Most Dangerous Malaria Strain
Researchers at KFSH&RC & KAUST Discover Gene Responsible for Reproduction of the Most Dangerous Malaria Strain King Faisal Specialist Hospital...
MangoRx Accepting Pre Orders for its “PRIME”, by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Product
The Dallas Based, Direct-to-Consumer Telemedicine Company to Offer 2 Months of Free ‘PRIME’ by MangoRx, Powered by Kyzatrex®️ (a $498...
Supernus Wins Infringement and Validity Case on Trokendi XR® against Torrent
ROCKVILLE, Md., Feb. 05, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and...
Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024
CAMBRIDGE, Mass., Feb. 05, 2024 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine...
eFFECTOR Therapeutics to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference
SOLANA BEACH, Calif. and REDWOOD CITY, Calif., Feb. 05, 2024 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR), a leader...
Elicio Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
BOSTON, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio Therapeutics” or “Elicio”), a clinical-stage biotechnology company developing...